SPX4,128.44-11.62 -0.28%
DIA328.10-0.32 -0.10%
IXIC12,540.84-103.62 -0.82%

Myovant Sciences Q1 EPS $(0.22) Beats $(0.30) Estimate, Sales $116.49M Beat $91.30M Estimate

Myovant Sciences (NYSE:MYOV) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $(0.30) by 26.67 percent. This is a 67.16 percent increase over losses of $(0.67) per share from

Benzinga · 07/27/2022 16:36
Myovant Sciences (NYSE:MYOV) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $(0.30) by 26.67 percent. This is a 67.16 percent increase over losses of $(0.67) per share from the same period last year. The company reported quarterly sales of $116.49 million which beat the analyst consensus estimate of $91.30 million by 27.59 percent. This is a 183.69 percent increase over sales of $41.06 million the same period last year.